7 min listen
Meletios Dimopoulos on relapsed and refractory multiple myeloma
Meletios Dimopoulos on relapsed and refractory multiple myeloma
ratings:
Length:
11 minutes
Released:
Oct 3, 2023
Format:
Podcast episode
Description
Professor Meletios Dimopoulos joins us to discuss two trials for patients with relapsed and refractory multiple myeloma - the first report of the DREAMM-3 phase 3 and long-term follow-up of the APOLLO phase 3 trial.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00243-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Released:
Oct 3, 2023
Format:
Podcast episode
Titles in the series (43)
INWORKS: The Lancet Haematology: June 29, 2015 by The Lancet Haematology in conversation with